肝星状细胞与抗肝纤维化治疗的研究进展

被引:12
作者
吴惠春
张斌
机构
[1] 上海中医药大学附属曙光医院肝病科
关键词
肝纤维化; 肝星状细胞; 治疗;
D O I
暂无
中图分类号
R575.2 [肝硬变];
学科分类号
100201 [内科学];
摘要
肝纤维化是肝脏对各种慢性损伤性刺激的修复反应。肝星状细胞的活化是整个事件的核心环节。以肝星状细胞为靶点,抑制其活化或者诱导其凋亡,进行抗肝纤维化研究有良好应用前景。
引用
收藏
页码:172 / 173
页数:2
相关论文
共 7 条
[1]
Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis[J] Kitae Park;Sung Woo Hong;Wonhee Hur;Min-Young Lee;Jeong-A. Yang;Sung Woo Kim;Seung Kew Yoon;Sei Kwang Hahn Biomaterials 2011,
[2]
S-adenosylmethionine prevents the up regulation of Toll-like receptor (TLR) signaling caused by chronic ethanol feeding in rats[J] Joan Oliva;Fawzia Bardag-Gorce;Jun Li;Barbara A. French;Samuel W. French Experimental and Molecular Pathology 2011,
[3]
The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats[J] Qing Lang;Qi Liu;Ning Xu;Ke-Li Qian;Jing-Hu Qi;Yin-Chun Sun;Lang Xiao;Xiao-Feng Shi Biochemical and Biophysical Research Communications 2011,
[4]
Targeting transforming growth factor β RII expression inhibits the activation of hepatic stellate cells and reduces collagen synthesis[J] Rongquan Fu;Jinguo Wu;Jiguang Ding;Jifang Sheng;Liang Hong;Qingfeng Sun;Hui Fang;Dairong Xiang Experimental Biology and Medicine 2011,
[5]
Anti‐PDGF‐B monoclonal antibody reduces liver fibrosis development[J] Shinji Ogawa;Takashi Ochi;Hideaki Shimada;Kazuyuki Inagaki;Isami Fujita;Aisuke Nii;Mark A. Moffat;Madan Katragadda;Bernard N. Violand;Robert H. Arch;Jaime L. Masferrer Hepatology Research 2010,
[6]
Silymarin treatment reduces granuloma and hepatic fibrosis in experimental schistosomiasis[J] Parasitology Research 2010,
[7]
Mechanisms of Hepatic Fibrogenesis[J] Scott L. Friedman Gastroenterology 2008,